Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sedona Sweeney

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Plos Medicine|November 8, 2017
Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling studyWilliam E Rudgard, Carlton A Evans, Sedona Sweeney, et al.
The Lancet. Global Health|June 28, 2025
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Health Economics|January 17, 2016
Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income CountriesSedona Sweeney, Anna Vassall, Nicola Foster, et al.
Plos Medicine|April 8, 2026
The benefits of investments to combat HIV, tuberculosis, and malaria for primary healthcare from 2000 to 2023: An economic modeling analysisJiaying Stephanie Su, John Stover, Carel Pretorius, et al.
PLOS Global Public Health|March 24, 2023
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosisSedona Sweeney, Catherine Berry, Emil Kazounis, et al.
Tropical Medicine & International Health : TM & IH|February 25, 2015
The health system burden of chronic disease care: an estimation of provider costs of selected chronic diseases in UgandaStella Nalukwago Settumba, Sedona Sweeney, Janet Seeley, et al.
Health Policy and Planning|February 17, 2017
The patient costs of care for those with TB and HIV: a cross-sectional study from South AfricaDon Mudzengi, Sedona Sweeney, Piotr Hippner, et al.
Health Policy and Planning|July 30, 2013
The costs of accessible quality assured syphilis diagnostics: informing quality systems for rapid syphilis tests in a Tanzanian settingSedona Sweeney, Jacklin F Mosha, Fern Terris-Prestholt, et al.
The Lancet. Global Health|May 18, 2024
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysisTheresa S Ryckman, Samuel G Schumacher, Christian Lienhardt, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Plos Medicine|November 8, 2017
Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling studyWilliam E Rudgard, Carlton A Evans, Sedona Sweeney, et al.
The Lancet. Global Health|June 28, 2025
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2024
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysisMelike Hazal Can, Sedona Sweeney, Brian W Allwood, et al.
Health Economics|January 17, 2016
Methodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income CountriesSedona Sweeney, Anna Vassall, Nicola Foster, et al.
Plos Medicine|April 8, 2026
The benefits of investments to combat HIV, tuberculosis, and malaria for primary healthcare from 2000 to 2023: An economic modeling analysisJiaying Stephanie Su, John Stover, Carel Pretorius, et al.
PLOS Global Public Health|March 24, 2023
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosisSedona Sweeney, Catherine Berry, Emil Kazounis, et al.
Tropical Medicine & International Health : TM & IH|February 25, 2015
The health system burden of chronic disease care: an estimation of provider costs of selected chronic diseases in UgandaStella Nalukwago Settumba, Sedona Sweeney, Janet Seeley, et al.
Health Policy and Planning|February 17, 2017
The patient costs of care for those with TB and HIV: a cross-sectional study from South AfricaDon Mudzengi, Sedona Sweeney, Piotr Hippner, et al.
Health Policy and Planning|July 30, 2013
The costs of accessible quality assured syphilis diagnostics: informing quality systems for rapid syphilis tests in a Tanzanian settingSedona Sweeney, Jacklin F Mosha, Fern Terris-Prestholt, et al.
The Lancet. Global Health|May 18, 2024
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysisTheresa S Ryckman, Samuel G Schumacher, Christian Lienhardt, et al.
Pageof 6